A “sundowner” is a person experiencing sundown syndrome, a pattern of worsening confusion, agitation, and behavioral changes that emerges in the late afternoon or evening. It most commonly affects people with dementia or Alzheimer’s disease. The symptoms typically begin around sunset and can last into the night, which is where the name comes from.
What Sundowning Looks Like
Sundowning involves an abrupt shift in behavior as the day winds down. A person who was relatively calm and oriented during the morning may become noticeably different by late afternoon. The hallmark symptoms include increased confusion, anxiety, agitation, aggression, and restlessness. Pacing and wandering are common, and the person may ignore directions or become fearful. Some people experience severe delusions. These behaviors are often more distressing to caregivers than the daytime symptoms of dementia because they come on suddenly and can be difficult to redirect.
The pattern repeats on a near-daily basis for many people. It’s not a one-time episode but a recurring cycle tied to the time of day.
Why It Happens in the Evening
The brain has an internal clock, a small cluster of cells in the hypothalamus that regulates your sleep-wake cycle. In Alzheimer’s disease and other forms of dementia, this region undergoes physical damage, including shrinkage of its neurons and the buildup of tangled proteins. The result is a flattened circadian rhythm, meaning the brain loses its ability to clearly distinguish daytime wakefulness from nighttime rest. Activity levels become more uniform throughout the day, and the normal wind-down signals that prepare the body for sleep get disrupted.
Melatonin plays a central role here. This hormone, which the brain releases in response to darkness to prepare the body for sleep, decreases with normal aging but drops even further in people with Alzheimer’s. The pineal gland, which produces melatonin, can calcify as dementia progresses. Without adequate melatonin signaling, the brain doesn’t transition smoothly into a restful state. Instead, the onset of darkness triggers hyperactivity, which can manifest as aggression or wandering.
Stress hormones add another layer. People with dementia who experience sundowning tend to have significantly higher cortisol levels than those who don’t. Elevated cortisol in the evening fuels the agitation and anxiety that define the syndrome.
Triggers That Make It Worse
While the underlying cause is neurological, several environmental and physical factors can amplify sundowning or bring it on earlier in the day.
- Low light and shadows. As daylight fades, shifting shadows and dim rooms can distort perception. People with visual impairments are especially vulnerable. One documented case involved a person with macular degeneration who repeatedly developed classic sundowning symptoms as daylight shifted to twilight.
- Fatigue from the day’s activities. High levels of morning or midday activity can leave a person with dementia physically and mentally exhausted by afternoon. That fatigue lowers the threshold for irritability and confusion.
- Environmental noise and disruption. In care facilities, staff shift changes around 3:00 PM bring increased noise, unfamiliar faces, and general disruption. At home, the evening bustle of dinner preparation, children arriving, or television noise can have a similar effect.
- Caregiver fatigue. Caregivers are tired by evening too, and may be less patient or less attentive. The person with dementia can pick up on that shift in energy.
How Sundowning Is Identified
There is no blood test or brain scan that diagnoses sundown syndrome. Doctors and caregivers identify it based on a recognizable pattern: an abrupt onset of behavioral changes in a person with dementia, appearing during the evening or darker hours, and consisting of symptoms like aggression, wandering, agitation, delusions, or intense fear. The key diagnostic feature is the timing. If the same person is relatively stable during daytime hours but consistently deteriorates as evening arrives, that pattern points to sundowning.
Clinicians also look for contributing factors such as sleep disorders, pain, infections, or medication side effects that could mimic or worsen the symptoms. Ruling out these other causes is important because some are treatable on their own.
Managing Symptoms With Routine and Environment
The most effective first-line strategies don’t involve medication. They center on light, routine, and reducing overstimulation.
Daytime light exposure is one of the most important interventions. Sitting near a window, going for walks outside, or using a light therapy box helps reinforce the brain’s weakened circadian signals. The goal is to give the internal clock as much environmental input as possible so it can still distinguish day from night. At bedtime, the opposite applies: keep the room dark and quiet.
A stable, simplified daily routine reduces the cognitive load that builds up throughout the day. Fewer transitions, fewer unfamiliar people, and fewer competing stimuli all help. Activities should be spread through the day but not packed in. If naps are needed, they should be short and early. Exercise during the day promotes better sleep at night.
In the evening, the environment should shift deliberately toward calm. Turn down televisions, minimize background noise, and avoid introducing new or complex tasks. Playing soft music, reading aloud, working on a simple puzzle, or sharing a quiet snack can ease the transition. Keep familiar objects like family photos nearby. Make sure eyeglasses and hearing aids are in place, since sensory deprivation worsens confusion. Going to bed at the same time and in the same place every night reinforces the routine.
Melatonin and Other Treatments
Because melatonin levels are depleted in people with Alzheimer’s, supplementing it at bedtime has shown real benefit for sundowning. In one study, 7 out of 10 dementia patients with sleep disorders showed a significant decrease in sundowning after taking melatonin at bedtime. A longer-term study followed 14 Alzheimer’s patients for two to three years on daily melatonin, and sundowning became undetectable in 12 of them. Another study of 45 patients over four months confirmed both sleep improvement and suppression of sundowning.
Melatonin is generally well tolerated, which makes it an appealing option compared to stronger sedating medications that carry risks of falls, further confusion, and other side effects in older adults. Light therapy and melatonin are often used together, since both target the same disrupted circadian system from different angles.
For people whose sundowning doesn’t respond to environmental changes and melatonin alone, doctors may consider other medications on a case-by-case basis, typically weighing the severity of the behaviors against the risks of sedation in a frail or elderly person.
The Impact on Caregivers
Sundowning is one of the most commonly cited reasons families seek placement in a care facility. The behaviors are exhausting and unpredictable, and they strike at the end of the day when caregivers have the fewest reserves. Nighttime wandering raises safety concerns, aggression can be frightening, and the nightly cycle of escalation erodes sleep for everyone in the household. Understanding that sundowning has a biological basis, not a willful one, can help caregivers depersonalize the behavior. The person isn’t choosing to be difficult. Their brain’s internal clock is broken, and the falling darkness exposes that damage in a way the daytime does not.